ALBERT CASTELLON: Open Payments
NPI 1598828881 · CORAL SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 34 payments from 7 companies in 2025. Trend: 2023 $565 · 2024 $811 · 2025 $797
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $224 |
| Otsuka America Pharmaceutical, Inc. | 8 | $170 |
| Vanda Pharmaceuticals Inc. | 5 | $141 |
| Janssen Pharmaceuticals, Inc | 5 | $112 |
| Alkermes, Inc. | 4 | $83 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| ABBVIE INC. | 1 | $26 |
Products named: INGREZZA, FANAPT, ABILIFY MAINTENA, INVEGA SUSTENNA, REXULTI, VIVITROL, Auvelity, ARISTADA.
Industry payments across FL — which companies pay providers there.
